Shukra Pharmaceuticals Ltd Approves Rs. 36 Crores Rights Issue

Shukra Pharmaceuticals Ltd announced the approval of a rights issue to raise funds up to Rs. 36 crores. The decision was made during a Board Meeting on 28th September, 2024. The rights issue will be made to the existing members of the company, with the price and right entitlement ratio to be decided by the Board. The offer is subject to necessary approvals and consent as required by applicable laws, including the SEBI (ICDR) Regulations, 2018, the SEBI (LODR) Regulations, 2015, and the Companies Act, 2013.